Range
5.21 - 5.48
Vol / Avg.
63.3K/99K
Div / Yield
-
52 Wk
3.12 - 11.42
Mkt Cap
49.9M
Payout Ratio
-
Open
5.27
P/E
-
EPS
-0.56
Shares
9.2M
Outstanding
9.2M
Total Float
9.2M
Benzinga - Apr 29, 2021, 4:15PM
load more
Sector: Health Care.Industry: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-10
REV
Q2 2021Est.ActualSurprise
EPS-0.500-0.560 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CYCCCyclacel Pharmaceuticals2.27%49.9M

Cyclacel Pharmaceuticals Questions & Anwsers

Q

How do I buy Cyclacel Pharmaceuticals (CYCC) stock?

A

You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ: CYCC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cyclacel Pharmaceuticals's (CYCC) competitors?

Q

What is the target price for Cyclacel Pharmaceuticals (CYCC) stock?

A

The latest price target for Cyclacel Pharmaceuticals (NASDAQ: CYCC) was reported by Oppenheimer on April 30, 2021. The analyst firm set a price target for 17.00 expecting CYCC to rise to within 12 months (a possible 214.81% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cyclacel Pharmaceuticals (CYCC)?

A

The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $5.4 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Cyclacel Pharmaceuticals (CYCC) pay a dividend?

A

There are no upcoming dividends for Cyclacel Pharmaceuticals. The last dividend paid out to investors was $0.10 on July 13, 2016.

Q

When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?

A
Cyclacel Pharmaceuticals’s Q3 earnings are confirmed for after-market on November 10, 2021.
Q

Is Cyclacel Pharmaceuticals (CYCC) going to split?

A

There is no upcoming split for Cyclacel Pharmaceuticals.

Q

What sector and industry does Cyclacel Pharmaceuticals (CYCC) operate in?

A

Cyclacel Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.